{"altmetric_id":735746,"counts":{"readers":{"mendeley":31,"citeulike":3,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["211767747087","214511418603111"],"posts_count":2},"blogs":{"unique_users_count":1,"unique_users":[369],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["medpage_today"],"posts_count":2},"total":{"posts_count":24},"twitter":{"unique_users_count":16,"unique_users":["Boxmed","nixon786","jer_a_smith","Senology","emiliomonteb","drschiler","gessieannelopes","CIMSFHUVH","1spiros","Amyloid_Planet","NEJM","medicineupdate","tomheston","mtmdphd","IMFnurseMyeloma","MyelomaFighter"],"posts_count":19}},"selected_quotes":["Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma \u2014 NEJM. #SGLS15 #myeloma","#ASH13 LD no maint reminds me of something.","Lenalidomida cont\u00ednua para mieloma m\u00faltiplo rec\u00e9m-diagnosticado (N Engl J Med)","LD no maint reminds me of something."],"citation":{"abstract":"Lenalidomide has tumoricidal and immunomodulatory activity against multiple myeloma. This double-blind, multicenter, randomized study compared melphalan-prednisone-lenalidomide induction followed by lenalidomide maintenance (MPR-R) with melphalan-prednisone-lenalidomide (MPR) or melphalan-prednisone (MP) followed by placebo in patients 65 years of age or older with newly diagnosed multiple myeloma.","abstract_source":"pubmed","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Antonio Palumbo","Roman Hajek","Michel Delforge","Martin Kropff","Maria Teresa Petrucci","John Catalano","Heinz Gisslinger","Wies\u0142aw Wiktor-J\u0119drzejczak","Mamia Zodelava","Katja Weisel","Nicola Cascavilla","Genadi Iosava","Michele Cavo","Janusz Kloczko","Joan Blad\u00e9","Meral Beksac","Ivan Spicka","Torben Plesner","Joergen Radke","Christian Langer","Dina Ben Yehuda","Alessandro Corso","Lindsay Herbein","Zhinuan Yu","Jay Mei","Christian Jacques","Meletios A. Dimopoulos","Palumbo A","Hajek R","Delforge M","Kropff M","Petrucci MT","Catalano J","Gisslinger H","Wiktor-J\u0119drzejczak W","Zodelava M","Weisel K","Cascavilla N","Iosava G","Cavo M","Kloczko J","Blad\u00e9 J","Beksac M","Spicka I","Plesner T","Radke J","Langer C","Ben Yehuda D","Corso A","Herbein L","Yu Z","Mei J","Jacques C","Dimopoulos MA"],"doi":"10.1056\/nejmoa1112704","endpage":"1769","first_seen_on":"2012-05-09T21:23:48+00:00","handles":[],"isbns":[],"issns":["0028-4793","1533-4406"],"issue":"19","journal":"New England Journal of Medicine","last_mentioned_on":1458092004,"links":["http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1112704","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/22571200\/","http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=%22The+New+England+journal+of+medicine%22%5BJour%5D+AND+2012%5Bpdat%5D+AND+Palumbo+A%5Bfirst+author%5D&cmd=detailssearch"],"pmid":"22571200","pubdate":"2012-05-10T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1759","subjects":["medicine"],"title":"Continuous lenalidomide treatment for newly diagnosed multiple myeloma.","type":"article","volume":"366","mendeley_url":"http:\/\/www.mendeley.com\/research\/continuous-lenalidomide-treatment-newly-diagnosed-multiple-myeloma-7"},"altmetric_score":{"score":27.95,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":27.95},"context_for_score":{"all":{"total_number_of_other_articles":8002981,"mean":6.7515998143141,"rank":293895,"this_scored_higher_than_pct":96,"this_scored_higher_than":7709518,"rank_type":"exact","sample_size":8002981,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":94411,"mean":5.2379318080712,"rank":2863,"this_scored_higher_than_pct":96,"this_scored_higher_than":91546,"rank_type":"exact","sample_size":94411,"percentile":96},"this_journal":{"total_number_of_other_articles":19684,"mean":47.106007214347,"rank":4955,"this_scored_higher_than_pct":74,"this_scored_higher_than":14724,"rank_type":"exact","sample_size":19684,"percentile":74},"similar_age_this_journal_3m":{"total_number_of_other_articles":279,"mean":71.229676258993,"rank":122,"this_scored_higher_than_pct":56,"this_scored_higher_than":157,"rank_type":"exact","sample_size":279,"percentile":56}}},"demographics":{"poster_types":{"member_of_the_public":11,"researcher":1,"practitioner":4},"users":{"twitter":{"cohorts":{"Members of the public":11,"Practitioners (doctors, other healthcare professionals)":4,"Scientists":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Librarian":1,"Researcher":7,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":5,"Student  > Postgraduate":2,"Other":4,"Student  > Master":4,"Student  > Bachelor":3,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":23,"Social Sciences":1,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":3,"Arts and Humanities":1}}},"geo":{"twitter":{"BR":2,"ES":2,"US":4,"BA":1,"CA":1},"mendeley":{"SE":1,"US":1,"JP":1,"TW":1,"BR":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Boxmed\/statuses\/231400446969933824","license":"public","citation_ids":[735746],"posted_on":"2012-08-03T14:45:40+00:00","author":{"name":"Boxmed","url":"http:\/\/t.co\/BBjaJrxyXJ","image":"http:\/\/a0.twimg.com\/profile_images\/353302387\/boxmed3_normal.JPG","description":"Portal m\u00e9dico para profissionais da \u00e1rea de sa\u00fade.\r\nVagas de trabalho para m\u00e9dicos, concursos, not\u00edcias e congressos.","id_on_source":"Boxmed","tweeter_id":"63536397","geo":{"lt":-14.242916,"ln":-51.412289,"country":"BR"},"followers":706},"tweet_id":"231400446969933824"},{"url":"http:\/\/twitter.com\/#!\/nixon786\/status\/200335394611531776","citation_ids":[735746],"posted_on":"2012-05-09T21:24:14+00:00","author":{"name":"nixon786","image":"https:\/\/pbs.twimg.com\/profile_images\/1726581351\/002_arabskie_loshadki_normal.jpg","description":"Physician investing in Biotech. Not an investment advise or recommendation to buy & sell. Please do your own DD.","id_on_source":"nixon786","tweeter_id":"314061974","geo":{"lt":null,"ln":null},"followers":1289},"tweet_id":"200335394611531776"},{"url":"http:\/\/twitter.com\/#!\/jer_a_smith\/status\/200356067534843907","rt":["nixon786"],"citation_ids":[735746],"posted_on":"2012-05-09T22:46:23+00:00","author":{"name":"Jeremy Smith","image":"http:\/\/a0.twimg.com\/profile_images\/3474784079\/9ccd4876fbff0c01ff84034c8d221baa_normal.jpeg","description":"I love Michigan sports, the stock market and oh yeah my better half (the boss) @JennSmith723","id_on_source":"jer_a_smith","tweeter_id":"188068145","followers":61},"tweet_id":"200356067534843907"},{"url":"http:\/\/twitter.com\/#!\/Senology\/status\/200513711587340288","citation_ids":[735746,735753],"posted_on":"2012-05-10T09:12:48+00:00","author":{"name":"Senology","url":"http:\/\/www.senology.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1301293396\/logo_style_normal.JPG","description":"Senology.org is the official web site of the International Senologic and Oncologic Scientific Community (ISOSC) - breast diseases and cancer diagnosis and care","id_on_source":"Senology","tweeter_id":"203469783","geo":{"lt":null,"ln":null},"followers":1871},"tweet_id":"200513711587340288"},{"url":"http:\/\/twitter.com\/#!\/emiliomonteb\/status\/200603833720778752","citation_ids":[735746],"posted_on":"2012-05-10T15:10:55+00:00","author":{"name":"Emilio Monte","url":"https:\/\/www.linkedin.com\/in\/emilio-monte-boquet-67032624\/","image":"https:\/\/pbs.twimg.com\/profile_images\/898548741422153728\/en1Mia9R_normal.jpg","description":"#Farmacia #HospitalLaFe #HospitalPharmacy PharmD PhD #eSalud #eHealth #Sherpas20 @ufpelafe @eDruida_","id_on_source":"emiliomonteb","tweeter_id":"51391835","geo":{"lt":39.5,"ln":-0.75,"country":"ES"},"followers":3662},"tweet_id":"200603833720778752"},{"url":"http:\/\/twitter.com\/#!\/drschiler\/status\/200653184975372288","citation_ids":[735746],"posted_on":"2012-05-10T18:27:01+00:00","author":{"name":"odilest Guerrier J ","image":"http:\/\/a0.twimg.com\/profile_images\/2030834454\/IMG00120-20110823-1839_normal.jpg","description":"med student . university pontificia catolica madre y maestra ","id_on_source":"drschiler","tweeter_id":"272660007","followers":37},"tweet_id":"200653184975372288"},{"url":"http:\/\/twitter.com\/#!\/drschiler\/status\/200652845672972288","citation_ids":[735746],"posted_on":"2012-05-10T18:25:41+00:00","author":{"name":"odilest Guerrier J ","image":"http:\/\/a0.twimg.com\/profile_images\/2030834454\/IMG00120-20110823-1839_normal.jpg","description":"med student . university pontificia catolica madre y maestra ","id_on_source":"drschiler","tweeter_id":"272660007","followers":37},"tweet_id":"200652845672972288"},{"url":"http:\/\/twitter.com\/#!\/gessieannelopes\/status\/200817833586864128","citation_ids":[735746],"posted_on":"2012-05-11T05:21:17+00:00","author":{"name":"Gessie Anne Lopes MD","url":"http:\/\/lattes.cnpq.br\/5740579079906873","image":"https:\/\/pbs.twimg.com\/profile_images\/2142260793\/41386_1780801541_1390_n_normal.jpg","description":"M\u00e9dica Internista, Oncologista e Hematologista pela PUC\/RS. Bacharelado em Filosofia UFRGS. Titular Especialista da SBC,  ABHH e SBTMO. Embaixadora MSF-BRAZIL.","id_on_source":"gessieannelopes","tweeter_id":"52304814","geo":{"lt":-30.03306,"ln":-51.23,"country":"BR"},"followers":742},"tweet_id":"200817833586864128"},{"url":"http:\/\/twitter.com\/#!\/CIMSFHUVH\/status\/200908106039951360","citation_ids":[735746],"posted_on":"2012-05-11T11:19:59+00:00","author":{"name":"CIMSFHUVH","url":"http:\/\/www.vhebron.net","image":"https:\/\/pbs.twimg.com\/profile_images\/3466781011\/7f351a83b9eef25e4a9214a6dc36b8d9_normal.jpeg","description":"Centre d\u2019Informaci\u00f3 de Medicaments.Servei de Farm\u00e0cia. Hospital Universitari Vall d\u2019Hebron. ICS. Departament de Salut. Generalitat de Catalunya","id_on_source":"CIMSFHUVH","tweeter_id":"215384125","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":2566},"tweet_id":"200908106039951360"},{"url":"http:\/\/twitter.com\/1spiros\/statuses\/271752656681312256","license":"datasift","citation_ids":[735746],"posted_on":"2012-11-22T23:10:56+00:00","author":{"name":"Spiros","url":"http:\/\/www.howcelebritiesloseweight.com","image":"http:\/\/a0.twimg.com\/profile_images\/591382030\/sg_normal.gif","description":"A professional is an amateur that never gave up!","id_on_source":"1spiros","tweeter_id":"99224938","geo":{"lt":34.05349,"ln":-118.245319,"country":"US"},"followers":78},"tweet_id":"271752656681312256"},{"url":"http:\/\/twitter.com\/Amyloid_Planet\/status\/409789217942695936","license":"public","citation_ids":[735746],"posted_on":"2013-12-08T20:58:57+00:00","author":{"name":"Dr. Jeffrey Zonder","url":"http:\/\/www.amyloidplanet.com","image":"https:\/\/pbs.twimg.com\/profile_images\/860371247045201920\/YqnTch_C_normal.jpg","description":"Hematologist fighting #myeloma & #amyloidosis @ Karmanos Cancer Institute in Detroit, MI #mmsm disclosures\/COI @ http:\/\/www.amyloidplanet.com\/p\/about.html?m=1","id_on_source":"Amyloid_Planet","tweeter_id":"1138405094","geo":{"lt":null,"ln":null},"followers":2118},"tweet_id":"409789217942695936"},{"url":"http:\/\/twitter.com\/Amyloid_Planet\/status\/409790800524886018","license":"public","citation_ids":[735746],"posted_on":"2013-12-08T21:05:15+00:00","author":{"name":"Dr. Jeffrey Zonder","url":"http:\/\/www.amyloidplanet.com","image":"https:\/\/pbs.twimg.com\/profile_images\/860371247045201920\/YqnTch_C_normal.jpg","description":"Hematologist fighting #myeloma & #amyloidosis @ Karmanos Cancer Institute in Detroit, MI #mmsm disclosures\/COI @ http:\/\/www.amyloidplanet.com\/p\/about.html?m=1","id_on_source":"Amyloid_Planet","tweeter_id":"1138405094","geo":{"lt":null,"ln":null},"followers":2118},"tweet_id":"409790800524886018"},{"url":"http:\/\/twitter.com\/#!\/NEJM\/status\/200334434535342080","citation_ids":[735746],"posted_on":"2012-05-09T21:20:25+00:00","author":{"name":"NEJM","url":"http:\/\/NEJM.org","image":"https:\/\/pbs.twimg.com\/profile_images\/893483773362393088\/US3DliFV_normal.jpg","description":"The New England Journal of Medicine (http:\/\/NEJM.org) is the world\u2019s leading medical journal and website.","id_on_source":"NEJM","tweeter_id":"25950355","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":449356},"tweet_id":"200334434535342080"},{"url":"http:\/\/twitter.com\/#!\/medicineupdate\/status\/201113584917417984","citation_ids":[735746],"posted_on":"2012-05-12T00:56:29+00:00","author":{"name":"Tom","url":"http:\/\/j.gs\/1K3w","image":"https:\/\/pbs.twimg.com\/profile_images\/3388626222\/3c70af58befec0257424ebde88c5f261_normal.png","description":"The top 5 internal medicine journals","id_on_source":"medicineupdate","tweeter_id":"174988635","geo":{"lt":null,"ln":null},"followers":3334},"tweet_id":"201113584917417984"},{"url":"http:\/\/twitter.com\/#!\/tomheston\/status\/201116864515014656","citation_ids":[735746],"posted_on":"2012-05-12T01:09:31+00:00","author":{"name":"Tom Heston","url":"http:\/\/tomheston.com","image":"https:\/\/pbs.twimg.com\/profile_images\/452650157050302464\/-kGG7sgd_normal.png","description":"I help people make wise health decisions. Theese are my medical newsfeed tweets. Follow @tomhestonmd for my personal tweets.","id_on_source":"tomheston","tweeter_id":"21013461","geo":{"lt":44.25,"ln":17.83333,"country":"BA"},"followers":83235},"tweet_id":"201116864515014656"},{"url":"http:\/\/twitter.com\/mtmdphd\/status\/392127518456950784","license":"public","citation_ids":[735746],"posted_on":"2013-10-21T03:17:40+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"392127518456950784"},{"url":"https:\/\/twitter.com\/IMFnurseMyeloma\/status\/624671188539719680","license":"datasift","citation_ids":[735746],"posted_on":"2015-07-24T20:03:11+00:00","author":{"name":"Teresa Miceli","image":"https:\/\/pbs.twimg.com\/profile_images\/804287812006715392\/CMFsFLTs_normal.jpg","description":"#BMT RN, #MYELOMA SGL, #EMPOWERING PATIENTS THRU #EDUCATION. My posts-not Mayo or IMF.","id_on_source":"IMFnurseMyeloma","tweeter_id":"961398000","geo":{"lt":44.02163,"ln":-92.4699,"country":"US"},"followers":468},"tweet_id":"624671188539719680"},{"url":"https:\/\/twitter.com\/MyelomaFighter\/status\/625045151229059072","license":"datasift","rt":["IMFnurseMyeloma"],"citation_ids":[735746],"posted_on":"2015-07-25T20:49:11+00:00","author":{"name":"Yvon Papillon","url":"http:\/\/my-multiple-myeloma.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/612814625072152576\/fGsBUr2e_normal.jpg","description":"Diagnosed Stage III Multiple Myeloma 06\/03, had  first BMT on 07\/05. remission for 4 1\/2 years. Had my second BMT Jan.2011  3 year remission. Now it's round 3!","id_on_source":"MyelomaFighter","tweeter_id":"217173395","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":1032},"tweet_id":"625045151229059072"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/692439522601222146","license":"gnip","citation_ids":[735746],"posted_on":"2016-01-27T20:10:21+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"692439522601222146"}],"news":[{"title":"3 Meds Better Than 2 for Older Myeloma Patients (CME\/CE)","url":"http:\/\/www.medpagetoday.com\/MeetingCoverage\/ASHHematology\/43395","license":"public","citation_ids":[735746],"posted_on":"2013-12-12T17:30:00+00:00","summary":"NEW ORLEANS (MedPage Today) -- Second progression-free survival (PFS2) increased significantly in older patients with multiple myeloma treated with a three-drug regimen and maintenance instead of a doublet with no maintenance, a randomized trial showed.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}},{"title":"Maintenance Tx in MM: No Advantages With Revlimid","url":"http:\/\/ct.moreover.com\/?a=25825073552&p=1pl&v=1&x=au2TXFIVX2zt8h1CAepr8w","license":"public","citation_ids":[6194986,6194987,6194988,735746,2112260],"posted_on":"2016-03-16T01:33:24+00:00","summary":"Action Points Melphalan (Alkeran), prednisone, and lenalidomide (MPR), followed by lenalidomide (Revlimid) maintenance therapy (MPR-R) was not superior to melphalan, prednisone, and thalidomide (Immunoprin) followed by thalidomide maintenance for\u2026","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}}],"facebook":[{"title":"Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10150854603577088&id=211767747087","citation_ids":[735746],"posted_on":"2012-05-10T08:38:56+00:00","summary":"New England Journal of Medicine, Volume 366, Issue 19, Page 1759-1769, May 2012.","author":{"name":"Medicina Familiar, General, Rural y Comunitaria","url":"https:\/\/www.facebook.com\/211767747087","facebook_wall_name":"Medicina Familiar, General, Rural y Comunitaria","image":"https:\/\/graph.facebook.com\/211767747087\/picture","id_on_source":"211767747087"}},{"title":"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1112704?query=featured_home","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=295373970550315&id=214511418603111","citation_ids":[735746],"posted_on":"2012-05-11T19:44:47+00:00","summary":"Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma\n\n\n\nhttp:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1112704?query=featured_home","author":{"name":"MLO- Medical Laboratory Observer","url":"https:\/\/www.facebook.com\/214511418603111","facebook_wall_name":"MLO - Medical Laboratory Observer","image":"https:\/\/graph.facebook.com\/214511418603111\/picture","id_on_source":"214511418603111"}}],"blogs":[{"title":"Richard Lehman\u2019s journal review \u2013 14 May 2012","url":"http:\/\/feeds.bmj.com\/~r\/bmj\/blogs\/~3\/1A7ez61e_i0\/","citation_ids":[668892,22875799,735746,735753,735756,736180,664840,736252,737861,679664,678489,735184,733087],"posted_on":"2012-05-14T13:12:00+00:00","summary":"Tweet JAMA\u00a0 9 May 2012\u00a0 Vol 307 1925\u00a0\u00a0\u00a0 In a wonderful letter to Humphry Davy in 1800, Coleridge declared that science, as a human activity, &#8220;being necessarily performed with the Passion of hope, is poetical.&#8221; All good science is inspired with","author":{"name":"Latest BMJ blogs","url":"http:\/\/blogs.bmj.com\/bmj","description":"Just another blogs.bmj.com weblog"}}]}}